T1 Condition 1410 1433  breast cancer patients
T2 Condition 815 822 patient
T3 Intervention 1152 1161 endocrine
T4 Condition 1425 1432 patient
T5 Level 1470 1479 tamoxifen
T6 Level 777 786 tamoxifen
T7 Level 109 118 tamoxifen
T8 Intervention 568 581 mitochondrial
T10 Biomarker 640 651 glutathione
T11 Protein 179 191 ~20 proteins
T13 Condition 801 823 breast cancer patients
T14 Condition 1376 1383 patient
T15 Gene 424 437 NQO1 and GCLC
T16 Intervention 1444 1453 endocrine
T17 Level 965 974 tamoxifen
T18 Protein 28 37 molecular
T19 Gene 1349 1358 NQO1 mRNA
T20 Protein 902 916 NQO1 inhibitor
T21 Level 282 291 tamoxifen
T22 Level 143 168 human breast cancer cells
T23 Gene 1349 1353 NQO1
T25 Gene 433 437 GCLC
T26 Condition 1116 1131  breast cancers
T27 Condition 1295 1300 tumor
T28 Gene 424 428 NQO1
T29 Protein 608 611 ATP
T30 Condition 800 823  breast cancer patients
T31 Level 399 410 MCF-7 cells
T32 Level 282 312 tamoxifen-resistant cell lines
T33 Gene 324 329 cDNAs
T35 Gene 714 718 NQO1
T36 Level 497 506 tamoxifen
T37 Biomarker 918 928 dicoumarol
T38 Gene 1220 1224 NQO1
T39 Gene 714 727 NQO1 and GCLC
T40 Gene 902 906 NQO1
